Original Article
Frequency of ARMD in the Local Pakistani Population
Presenting at a Tertiary Care Hospital
Hussain
Ahmad Khaqan, Usman Imtiaz,
Hassan Raza, Umrah Imran, Ateeq-ur-Rehman
Pak J Ophthalmol 2018, Vol. 34, No. 3
. . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .. .
.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
See end of article for authors affiliations
..
.. Correspondence to: Dr. Hussain Ahmad Khaqan FRCS
Associate Professor Department
of Ophthalmology Lahore General Hospital |
Purpose: To evaluate the frequency of ARMD in local Pakistan population presenting at a
tertiary care hospital. Study Design: Cross sectional descriptive study. Place and Duration of Study: Lahore
General Hospital from 1st October 2015 to30th
March 2018. Material and Methods: A total of 1002 participants with age above 65 years were
included. Participants with clear ocular media were
selected randomly from outpatient department. Informed consent was taken from
all participants for taking retinal images. A non-mydriatic 8 megapixel (MP) Topcon fundus
camera was used to take 45 degree retinal images. Fundus fluorescein angiography was done in patients having ARMD and they were
treated accordingly. A proforma was designed to collect data including age,
sex, smoking, far and near vision and status of retina (ARMD present or not
and its type). Blood pressure, serum
cholesterol, weight, and
height of persons having ARMD were recorded. Results: A
total of 1020 participants were included in study. There were 500 (49%) males
and 520 (51%) females. Mean age of participants was 70.3±5 years. Frequency of ARMD was found to be 1.56% in local population. Prevalence of dry ARMD (68.75%) was greater
than wet ARMD (31.25%). There was no significant gender predisposition for
ARMD. Among all risk factors of ARMD smoking (41%) had strong association
while hypertention (24%), diabetes (12%), hyperlipidemia (15%) and
obesity (9%) had also some association with ARMD. Conclusion: Age related macular degeneration is most frequent in smokers and they should be educated
about this risk. Keywords: Age-Related Macular Degeneration, Hypertension, Diabetes, Obesity. |
Age Related Macular
Degeneration (ARMD) is one of the leading causes of blindness worldwide1. It
is a chronic disease that affects the part of retina, which is required for maximum fine details of vision.
According to an analysis 15 million people are affected with
ARMD in North America2.
Worldwide its documented prevalence is 5.6%3.
Age is one of the primary risk factors for ARMD, others
include smoking, obesity, hypertension, hypercholesterolemia, excessive sun exposure and a diet deficient in fruits and vegetables4.
There are two documented types of ARMD i.e. Dry and Wet ARMD (neovascular). Dry
form is more prevalent than wet ARMD but gross vision loss is associated with wet form of ARMD2.
ARMD can also be classified on the grounds of severity
i.e. early, intermediate and advanced ARMD5. Small to intermediate size drusens with no pigmentation are seen in early ARMD
while intermediate ARMD includes several intermediate size
drusen with at least one large size drusen (> 125 um)5.
Geographic atrophy and exudative ARMD are considered as advanced
forms of ARMD5. Symptoms of dry ARMD appear gradually and are usually
associated with difficulty
in adaptation to light or dark while wet ARMD is associated with profound loss
of central vision and metamophopsia6.
There
are many treatment modalities for wet
ARMD including intra-vitreal Anti
VEGF, intra-vitreal steroid, Laser photocoagulation and Photodynamic therapy7. Dry
ARMD does not have specific treatment but includes
prophylaxis and visual
rehabilitation8.
Anti oxidants and zinc supplements have an important role in
preventing ARMD in other eye9. These supplements are referred as "AREDS" supplements because
their efficacy was established by the National Eye Institute's
Age-Related Eye Disease Study9. Trials of other supplements i.e Leutin, xiazanthine
and omega-3 fatty acids are in progression of ARMD10. The purpose of our study was to find the frequency of ARMD
in a tertiary hospital and also determine associations with other conditions.
MATERIAL AND METHODS
A total of 1020 participants with age above 65 years were
included in the study. Participants with clear ocular media were selected
randomly from outpatient department. Informed consent was taken from all
participants for taking retinal images. Distance
visual acuity was recorded by using Snellens acuity chart while near vision was
recorded by using Jaegar near vision chart. A non-mydriatic 8 MP Topcon fundus
camera was used to take 45 degree retinal images. Fundus fluorescein
angiography was done in patients having ARMD and
treated accordingly. A proforma was designed to collect
data including age, gender, status of retina (ARMD present or not) and smoking.
All images and data were collected by the same person.
Associations of ARMD i.e. smoking, hyperlipidemia,
hypertension, diabetes and obesity were also evaluated. Patients
with known history of hypertension and those with blood pressure of > 150/90
mm Hg were labeled as hypertensive. Patients with known history of diabetes
and those with fasting blood sugar level of > 7 mmol were
considered as diabetics. Participants with fasting lipid profile more than 250 mg/dl were
considered hyperlipidemic. Height and weight were measured. Body mass index was
calculated using the formula: weight (in KGs)/(height
Χ height) (in meters).
ARMD was graded according to international classification.
Digital fundus photography was done including colored as well as red free
images. Dry ARMD included drusens and geographic atrophy with respect to severity of disease. Wet ARMD included disorders of choriocapillary plexus
including choroidal neovascular
membranes (CNVM) and pigment epithelial detachment (PED).
We
assumed that the proportion of ARMD would be 5.6% according to a published
study4. To achieve 95% confidence interval
with acceptable error margin of 3%, we needed to examine 1020 persons of this
age group. Statistical analysis was done by SPSS version 20.
RESULTS
A
total of 1020 participants were included in this study. There were 500 (49%)
males and 520 (51%) females. Mean age of participants
was 70.3 ±5 years. Frequency of ARMD came out to be 1.56% (16/1000) in local
population. Prevalence of dry ARMD (68.75%) was greater than wet ARMD (31.25%).
There was no significant gender predisposition for ARMD. Age wise statistical
analysis is shown in Table 1.
Table 1: Age-wise distribution of ARMD in local
population.
Age Groups |
No. of
Persons (n) |
Percentage % |
ARMD (X) |
Percentage
ARMD % |
60 65 |
550 |
53.92 |
3 |
0.29 |
66 70 |
300 |
29.41 |
6 |
0.58 |
71 75 |
150 |
14.7 |
4 |
0.39 |
75 80 |
20 |
1.96 |
3 |
0.29 |
Fig. 1:
Percentage of Dry VS Wet ARMD.
Associations
of ARMD i.e. smoking, hyperlipidemia, hypertension and obesity were also evaluated. Among
all risk factors of ARMD smoking (41%) had the strongest
association while hypertension (24%), hyperlipidemia (15%), diabetes (12%) and
obesity (9%) had also some association with ARMD. (Fig 02)
Fig. 2: Risk factors for ARMD.
DISCUSSION
Age related macular degeneration (ARMD) is one of the leading causes of acquired blindness worldwide11. In
our study its prevalence came out to be 1.56%, which is quite lower than USA,
which is 5.6%3. Another study was conducted in India showing prevalence near to our study12.
Novartis Pharmaceuticals UK also
suggested 26,000 new cases of wet AMD in the UK per year, reported as being calculated
from our earlier review of prevalence. This figure is commensurate with
estimates that there are 13,000 to 37,000 incident cases of neovascular AMD in
England and Wales per year13.
A study was conducted to evaluate the difference in
prevalence of ARMD among black and white races; they concluded no significant
difference among these races with respect to prevalence rate. Mediums size drusen
were found equally in both races but in white race
they transformed to large size drusen later more frequently14.
Equal proportion of male and female were included in the study but there was no
gender predisposition for ARMD. There are many studies which showed the same pattern of gender predisposition15.
Another study showed that females are more prone to develop neovascular AMD
than males and associated with profound visual loss16.
Focal hyper-pigmentation was also evaluated in our study and found in only 5
patients (3 female and 2 male). A study conducted in
Baltimore suggested that focal hyper pigmentation was more prevalent
among white race as compared with black race people17.
A study was conducted in Brazil among Japanese immigrants
and they showed that ARMD was more prevalent in men
while in our study no such difference was noted. Maximum age group prone
to ARMD was 60-65 years of age group while in our study it came out to be 66-70
years of age group18. Another study showed that 66-70 years of age group is
most prone to develop ARMD, which is same as our study19. In our study we
observed that dry ARMD was more prevalent (68.75%) than wet ARMD (31.25%). These results are
consistent with published studies29,30. In contrast a study was published in UK showed that there is no significant difference of prevalence among dry
and wet ARMD20.
Dry ARMD is associated with gradual loss of vision while wet
ARMD is associated with sudden gross loss of vision12,13. In
our study, patients with wet ARMD were associated with gross drop in vision as compared with dry ARMD. Dry ARMD if
not treated can lead to wet form of ARMD (CNV or PED). Etiology of ARMD is not
well known but there are few documented predisposing factors i.e. smoking,
hypertension, hyperlipidemia, diabetes and obesity which my lead to ARMD4. In our study smoking was the most
significant predisposing
factor. According to a survey in USA smoking and hyperlipidemia were among the
most significant predisposing factors for developing ARMD21.
Body mass index is also an important predisposing factor for developing
ARMD but no association of high BMI was seen in our study.
There are some psychological issues like depression that
may predispose to ARMD as well22. Studies show that greater attention from families, physicians,
and society to the mental health needs and also alleviation of mobility challenges
may help improve the condition22.
Our study showed hypertension as the second significant
predisposing factor for ARMD. There are multiple studies showing relation of hypertension with ARMD17,22. A
study was conducted that showed that antihypertensive drugs
like systemic beta blockers reduce lysozyme levels. These drugs reduce the
requirement for intravitreal anti-VEGF injections in patients with wet
AMD23.
As there are few treatment
options for the management of ARMD so its prevention and retardation of growth
plays an important role. AREDS study was conducted to evaluate the role of
antioxidants in prevention
and delaying the disease process. AREDS explained that antioxidants i.e.
Beta carotene (15 mg), Vitamin C (500 mg), Vitamin E (400 IU), Zinc (80 mg) and copper (as cupric oxide)
are associated with remarkable delay in
progression of disease24.
Another clinical trial AREDS 2 was carried out to look for
efficacy of omega 3 fatty acids and Lutein/Zeaxanthin in
reducing the rate of progression of disease. AREDS 2 clinical trial explained that Omega 3 fatty acids
are of no importance when added with these supplements while lutein and zeaxanthin was associated with delay in progression of ARMD.
Beta carotene was found to be associated with increased risk of lung cancer25. In
this study 50% of patients were smoker while in our study 40% of patients were
smoker. According to different published studies smoking came out to be the most persistent risk factor in addition to all other
risk factors.
As
there is no such geographic data published regarding the prevalence and
incidence of age related macular degeneration in Pakistan so this will help to compare it
with other populations in East as well as in Western
countries. This evidence-based data can be used to provide health care and
social awareness to population and its comparison with other parts of the
world. This awareness can help to prevent further by following the international guidelines that will help in present as well as in
future.
CONCLUSION
Age
related macular degeneration is most
frequent in smokers and they should be educated about this.
Authors Affiliation
Dr.
Hussain Ahmad Khaqan
FRCS
Associate Professor
Department of Ophthalmology
Lahore
General Hospital
Dr.
Usman Imtiaz
FCPS,
Vitreo-retina fellow
Department
of Ophthalmology
Lahore
General Hospital
Dr.
Hassan Raza
MRCSED,
Final year PGR
Department
of Ophthalmology
Lahore
General Hospital
Dr.
Umrah Imran
MBBS, Final year PGR
Department
of Ophthalmology
Lahore
General Hospital
Dr. Ateeq-ur-Rehman
MBBS,
2nd year PGR
Department
of Ophthalmology
Lahore
General Hospital
Role of Authors
Dr.
Hussain Ahmad Khaqan
Conception
and Design, Literature Search
Dr.
Usman Imtiaz
Literature
Search, Critical Review, Manuscript editing
Dr.
Hassan Raza
Data
Collection, Manuscript writing
Dr.
Umrah Imran
Data
Collection, Manuscript writing
Dr. Ateeq-ur-Rehman
Data
Analysis, Data Collection, Literature Search
REFERENCES
1.
Klein R, Klein BE, Linton KL. Prevalence
of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology, 1992; 99
(6): 933943.
2.
American Academy of Ophthalmology. Retina and Vitreous.
American Academy of Ophthalmology Basic and Clinical Science Course, 2010-2011; 60-89.
3.
R. Klein, C F
Chou. Prevalence of Age-Related Macular
Degeneration in the US Population. Arch Ophthalmol. 2011; 129 (1): 75-80.
4.
Age-Related Eye Disease Study Research Group. Risk factors
associated with age-related macular degeneration: a case-control study in the
Age-Related Eye Disease Study.
Age-Related Eye Disease Study report number 3 Ophthalmology, 2000; 107:
222432.
5.
Age-Related Eye Disease Study Research Group. A randomized,
placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene and zinc for age-related
macular degeneration and vision loss:
AREDS report number 8. Arch Ophthalmol. 2001; 119: 1417-1436.
6.
Bakri SJ. Macular
Degeneration. Mayo Clinic Guide to Better Vision, 2007: 21-50.
7.
Votruba M, Gregor Z. Neovascular
age-related macular degeneration: present and future options. Eye, 2001; 15
(3): 42429.
8.
Reeves BC,
Harper RA, Russell WB. Enhanced low vision rehabilitation for people
with age related macular degeneration: a randomised
controlled trial. Br J Ophthalmol.
2004; 88 (11): 14439.
9.
Snodderly DM. Evidence for
protection against age-related macular degeneration by carotenoids and antioxidant
vitamins. Am J Clin Nutr. 1995:
1448-1461.
10. The
Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group, The effect
of vitamin E and beta carotene on the
incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;
1029-1035.
11. Friedman DS, O'Colmain BJ, Munoz B. Prevalence of
age related macular degeneration in the United States.
Arch Ophthalmol. 2004; 122: 564-72.
12. T Krishnan, R D Ravindran. Prevalence
of Early and Late Age-Related Macular Degeneration in India: The INDEYE Study. Invest
Ophthalmol Vis Sci. 2010 Feb; 51 (2): 701707.
13. Friedman
DSKatz Jbressler NMRahmani
Btielsch JM. Racial differences in the
prevalence of age-related macular degeneration: The Baltimore Eye Survey Ophthalmology,
1999; 106 (6) 1049-1055.
14. Naghza, N Karam. Epidemiology of Age
Related Macular Degeneration (AMD) and Its Associated Ocular
Conditions and Concomitant Systemic Diseases.Pak J Ophthalmol. 2013, Vol. 29 . 132-35.
15. Wong TY, Loon S-C, Saw SM. The
epidemiology of age related eye diseases in Asia. British J Ophthalmol. 2006;
50-56.
16. Thornton J, Edwards R, Mitchell P, et al. Smoking and
age-related macular degeneration: a review of association. Eye
(Lond), 2005; 19: 93544.
17. Coleman HR, Chan CC, Ferris FL, 3rd, Chew EY. Age-related
macular degeneration. Lancet. 2008; 372: 1835 45.
18. Arnarsson A, Sverrisson T, Stefαnsson E, Sigurdsson H, Sasaki H, Sasaki K, et al. Risk factors
for five-year incident age-related macular degeneration: The Reykjavik Eye
Study. Am J Ophthalmol. 2006; 142: 41928.
19.
Ferris FL Davis MD Clemons TE et al. The Age-Related Eye
Disease Study Research Group, A simplified severity scale for age-related macular degeneration: AREDS Report No.
18. Arch Ophthalmol. 2005; 123 (11): 1570-1574.
20. Zhou J, Pham L, Zhang N, He S, Gamulescu MA, Spee C, Ryan
SJ, Hinton DR. Neutrophils promote experimental choroidal
neovascularization. Molecular vision, 2005; 11: 414424.
21. Popescu ML, Boisjoly H, Schmaltz H, Kergoat MJ, Rousseau J,
Moghadaszadeh S, Djafari F, Freeman EE. Explaining
the relationship between three eye diseases and depressive symptoms in older
adults. Invest Ophthalmol Vis Sci. 2012: 2308-13.
22. Tatar O, Yoeruek E, Szurman P, Bartz-Schmidt KU, Adam A,
Shinoda K, Eckardt C, Boeyden V, Claes C, Pertile G, et al. Effect of
bevacizumab on inflammation and proliferation in human choroidal neovascularization.
Archives of ophthalmology, 2008; 126: 782790.
23.
Davis MD Gangnon RE Lee LY et al. The Age-Related Eye
Disease Study Research Group, The Age-Related Eye Disease Study Severity Scale
for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol.
2005; 123 (11) 1484-1498 [erratum published in Arch
Ophthalmol. 2006; 124 (2): 289-290].
24. Chong EW, Simpson JA, Robman LD, Hodge AM, Aung KZ, English
DR, et al. Red meat and chicken consumption and
its association with age-related macular degeneration. Am J Epidemiol. 2009;
169: 86776.
25.
Montero JA, Ruiz Moreno JM, Sanchis Merino
E, Perez Martin S: Systemic
beta-blockers may reduce the need for repeated intravitreal injections in
patients with wet age related macular degeneration treated by bevacizumab.
Retina. 2012; 24.
26. Age-Related
Eye Disease Study Research Group. A randomized,
placebo-controlled, clinical trial of high-dose supplementation with vitamins C
and E, beta carotene, and zinc for age-related macular degeneration and vision loss:
AREDS report no. 8. Arch Ophthalmol. 2001; 119 (10):
14171436.
27. Age-Related
Eye Disease Study 2 Research Group. Lutein +
zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the
Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013;
309: 20052015.